Edgewise Therapeutics (EWTX)
(Delayed Data from NSDQ)
$22.20 USD
-0.67 (-2.93%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $22.20 0.00 (0.00%) 5:36 PM ET
2-Buy of 5 2
D Value F Growth B Momentum D VGM
Brokerage Reports
Edgewise Therapeutics, Inc. [EWTX]
Reports for Purchase
Showing records 1 - 20 ( 73 total )
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Adding EWTX to Best Ideas List Ahead of Strong Catalyst Line-Up
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
How Does DMD Drug Development Change Post-Elevidys?
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ARCH Data Continues to Show Stabilization - More Readouts To Come
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... Cardiac In Focus As ARCH Data Arrives
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Let''s Get It Started -- Multiple Readouts Approaching
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Muscling Up The Balance Sheet Ahead Of Catalyst Rich 2024; Adding In EDG-7500
Provider: Wedbush Securities Inc.
Analyst: CHICO L